Heat-labile enterotoxin (LT) and mutation, which is commonly used as mucosal adjuvant, can priming humoral and cell immunity. So LT and mutation will be used in mucosal vaccine.
大肠杆菌不耐热肠毒素(Heat-labile enterotoxin, LT)及其突变体是一种常用的粘膜佐剂,可有效启动机体局部和系统的体液免疫和细胞免疫,成为粘膜疫苗研究的主要佐剂。
参考来源 - 幽门螺杆菌多亚单位疫苗的筛选及免疫保护机制研究·2,447,543篇论文数据，部分数据来源于NoteExpress
LT is a powerful immunogen and mucosal adjuvant when co-administered with soluble antigens.
LT具有很强的免疫原性和黏膜免疫佐剂活性。
The article gives a detail summarization on the recent studies about mucosal immune adjuvant.
本文就近几年来国内外黏膜免疫佐剂的研究情况作一综述。
In order to improve organism mucosal immunity and system immune response against the antigen, different kinds of mucosal immune adjuvant have been studied.
因此为了提高机体对抗原的黏膜免疫力和系统免疫反应，不同类型黏膜免疫佐剂已悄然进入黏膜免疫的研究中。
应用推荐